Åke Lernmark Selected Research

HLA-DQ Antigens (HLA-DQ)

1/2021	Nine residues in HLA-DQ molecules determine with susceptibility and resistance to type 1 diabetes among young children in Sweden.
11/2020	Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes.
1/2020	Decreased HLA-DQ expression on peripheral blood cells in children with varying number of beta cell autoantibodies.
1/2020	Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children.
1/2018	Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children.
11/2017	Are Perinatal Events Risk Factors for Childhood Thyroid Autoimmunity?
1/2017	An Increased Diagnostic Sensitivity of Truncated GAD65 Autoantibodies in Type 1 Diabetes May Be Related to HLA-DQ8.
1/2017	Thyroid and Islet Autoantibodies Predict Autoimmune Thyroid Disease at Type 1 Diabetes Diagnosis.
12/2015	Neuropeptide Y is a minor autoantigen in newly diagnosed type 1 diabetes patients.
3/2015	A method for reporting and classifying acute infectious diseases in a prospective study of young children: TEDDY.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Åke Lernmark Research Topics

Disease

77	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2011
12	Insulinoma 10/2021 - 02/2012
8	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 06/2015
8	Celiac Disease (Celiac Sprue) 01/2022 - 11/2015
8	Narcolepsy 01/2021 - 05/2014
8	Infections 10/2018 - 03/2015
6	Type 2 Diabetes Mellitus (MODY) 01/2020 - 03/2011
4	Disease Progression 01/2022 - 01/2019
3	Hyperglycemia 01/2022 - 01/2011
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 12/2017
3	Sleep Wake Disorders 04/2020 - 05/2014
3	Human Influenza (Influenza) 01/2019 - 05/2014
2	Insulin Resistance 01/2018 - 06/2015
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 10/2017
2	Thyroid Diseases (Thyroid Disease) 11/2017 - 01/2017
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2021
1	Glucose Intolerance 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Obesity 01/2021
1	Persistent Infection 01/2020
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2020
1	Ketosis 01/2020
1	Genetic Risk Score 01/2019
1	Multiple Sclerosis 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Rheumatic Diseases (Rheumatism) 11/2017
1	Rotavirus Infections 05/2017
1	Chronic Disease (Chronic Diseases) 03/2017
1	Fever (Fevers) 01/2017

Drug/Important Bio-Agent (IBA)

59	AutoantibodiesIBA 01/2022 - 03/2011
29	Insulin (Novolin)FDA Link 01/2022 - 06/2013
13	HLA-DQ Antigens (HLA-DQ)IBA 01/2021 - 08/2012
9	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2022 - 02/2012
9	AntibodiesIBA 01/2021 - 06/2013
8	AntigensIBA 07/2021 - 01/2016
6	Zinc Transporter 8IBA 01/2020 - 08/2011
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2015
5	VaccinesIBA 01/2021 - 01/2016
5	AutoantigensIBA 01/2021 - 10/2013
5	Amino Acids FDA Link 11/2020 - 10/2013
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 01/2016
4	C-PeptideIBA 01/2020 - 05/2013
4	HLA-DQB1 antigen (HLA DQB1)IBA 01/2019 - 03/2011
4	pandemrixIBA 01/2019 - 05/2014
3	OrexinsIBA 04/2020 - 05/2014
3	HLA-DR Antigens (HLA-DR)IBA 01/2020 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2014
3	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2018 - 01/2016
3	Immunoglobulin M (IgM)IBA 01/2018 - 01/2012
2	HLA-DRB1 Chains (HLA DRB1)IBA 07/2021 - 01/2019
2	HLA-DQA1 antigen (HLA DQA1)IBA 11/2020 - 01/2020
2	P-2 (P 2)IBA 01/2020 - 01/2016
2	HLA-DRB3 Chains (HLA DRB3)IBA 01/2019 - 03/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2017 - 01/2016
2	Glutens (Glutelin)IBA 05/2017 - 03/2016
2	CarbohydratesIBA 01/2017 - 01/2011
2	HLA-DQ8 antigenIBA 01/2017 - 06/2013
2	Immunoglobulin G (IgG)IBA 11/2015 - 01/2012
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 07/2021
1	TransglutaminasesIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	VitaminsIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	LipidsIBA 10/2020
1	ProteomeIBA 04/2020
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	GlucokinaseIBA 01/2020
1	glutamate decarboxylase 2IBA 01/2020
1	alpha-MSHIBA 01/2019
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2019
1	Orexin ReceptorsIBA 01/2019
1	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 01/2019
1	AnoctaminsIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Chloride Channels (Chloride Channel)IBA 01/2019
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 01/2019
1	prostaglandin D2 receptorIBA 01/2019
1	MicronutrientsIBA 10/2018
1	Glucagon (Glukagon)FDA Link 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	NucleoproteinsIBA 10/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017
1	Thyroglobulin FDA Link 01/2017
1	Iodide Peroxidase (Deiodinase)IBA 01/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017
1	Dichlororibofuranosylbenzimidazole (DRB)IBA 03/2016
1	Complement System Proteins (Complement)IBA 01/2016
1	LigandsIBA 01/2016
1	Neuropeptide YIBA 12/2015
1	Proline (L-Proline)FDA Link 12/2015
1	Leucine (L-Leucine)FDA Link 12/2015

Therapy/Procedure

2	Secondary Prevention 01/2022 - 06/2015
2	Therapeutics 01/2019 - 10/2015
1	Glycemic Control 01/2020
1	Cesarean Section (Caesarean Section) 01/2018